The nurse is administering insulin lispro (Humalog) and will keep in mind that this insulin will start to have an effect within which time frame?

Choice A rationale: Insulin lispro (Humalog) is a rapid-acting insulin analog. Its amino acid sequence has been modified to allow for rapid absorption from the injection site into the bloodstream. This modification prevents the formation of hexamers, which are slowly absorbed, allowing the insulin to become biologically active within 15 minutes of administration. Choice B rationale: Regular insulin, a short-acting type, typically has an onset of action of 30 to 60 minutes. Intermediate-acting insulins like NPH have a much longer onset, starting around 1 to 2 hours. Insulin lispro's rapid action is designed to be taken with meals to control postprandial hyperglycemia, which begins immediately after eating. Choice C rationale: An onset of 80 minutes falls outside the typical time frame for both rapid and short-acting insulins. The pharmacokinetics of insulin lispro are specifically engineered for a quick onset to coincide with mealtime glucose spikes, and its action is not delayed for over an hour. Choice D rationale: The peak effect of insulin lispro is around 1 to 2 hours, but its onset is much faster. Long-acting insulins like glargine (Lantus) have a much more prolonged effect, with a duration that can extend to 24 hours, but they lack a distinct peak. The 3 to 5 hour period is too long for the onset of a rapid-acting insulin.